BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24206565)

  • 1. Genotype-specific risk stratification and management of patients with long QT syndrome.
    Barsheshet A; Dotsenko O; Goldenberg I
    Ann Noninvasive Electrocardiol; 2013 Nov; 18(6):499-509. PubMed ID: 24206565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biology of the long QT syndrome: impact on management.
    Priori SG; Napolitano C; Paganini V; Cantù F; Schwartz PJ
    Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2052-7. PubMed ID: 9272507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital long QT syndromes: prevalence, pathophysiology and management.
    Barsheshet A; Dotsenko O; Goldenberg I
    Paediatr Drugs; 2014 Dec; 16(6):447-56. PubMed ID: 25288402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium channel blockers in the management of long QT syndrome types 3 and 2: A system review and meta-analysis.
    Yang Y; Lv TT; Li SY; Zhang P
    J Cardiovasc Electrophysiol; 2021 Nov; 32(11):3057-3067. PubMed ID: 34427958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long QT syndrome.
    Goldenberg I; Moss AJ
    J Am Coll Cardiol; 2008 Jun; 51(24):2291-300. PubMed ID: 18549912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.
    Schwartz PJ; Priori SG; Spazzolini C; Moss AJ; Vincent GM; Napolitano C; Denjoy I; Guicheney P; Breithardt G; Keating MT; Towbin JA; Beggs AH; Brink P; Wilde AA; Toivonen L; Zareba W; Robinson JL; Timothy KW; Corfield V; Wattanasirichaigoon D; Corbett C; Haverkamp W; Schulze-Bahr E; Lehmann MH; Schwartz K; Coumel P; Bloise R
    Circulation; 2001 Jan; 103(1):89-95. PubMed ID: 11136691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.
    Schwartz PJ; Priori SG; Locati EH; Napolitano C; Cantù F; Towbin JA; Keating MT; Hammoude H; Brown AM; Chen LS; Colatsky TJ
    Circulation; 1995 Dec; 92(12):3381-6. PubMed ID: 8521555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.
    Priori SG; Napolitano C; Schwartz PJ; Grillo M; Bloise R; Ronchetti E; Moncalvo C; Tulipani C; Veia A; Bottelli G; Nastoli J
    JAMA; 2004 Sep; 292(11):1341-4. PubMed ID: 15367556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome.
    Shimizu W; Aiba T; Antzelevitch C
    Curr Pharm Des; 2005; 11(12):1561-72. PubMed ID: 15892662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of fatal arrhythmic events in long QT syndrome patients after syncope.
    Jons C; Moss AJ; Goldenberg I; Liu J; McNitt S; Zareba W; Qi M; Robinson JL
    J Am Coll Cardiol; 2010 Feb; 55(8):783-8. PubMed ID: 20170817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.
    Koponen M; Marjamaa A; Hiippala A; Happonen JM; Havulinna AS; Salomaa V; Lahtinen AM; Hintsa T; Viitasalo M; Toivonen L; Kontula K; Swan H
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):815-23. PubMed ID: 26063740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis, sudden death risk stratification, and treatment of main long QT syndrome molecular-genetic variants].
    Shkol'nikova MA; Kharlap MS; Il'darova RA; Bereznitskaia VV; Kalinin LA
    Kardiologiia; 2011; 51(5):50-61. PubMed ID: 21649595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management.
    Goldenberg I; Bradley J; Moss A; McNitt S; Polonsky S; Robinson JL; Andrews M; Zareba W;
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):893-901. PubMed ID: 20233272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.
    Zareba W; Moss AJ; Locati EH; Lehmann MH; Peterson DR; Hall WJ; Schwartz PJ; Vincent GM; Priori SG; Benhorin J; Towbin JA; Robinson JL; Andrews ML; Napolitano C; Timothy K; Zhang L; Medina A;
    J Am Coll Cardiol; 2003 Jul; 42(1):103-9. PubMed ID: 12849668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Long QT Syndrome.
    Vohra J
    Heart Lung Circ; 2007; 16 Suppl 3():S5-12. PubMed ID: 17627884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese Patients.
    Shimizu W; Makimoto H; Yamagata K; Kamakura T; Wada M; Miyamoto K; Inoue-Yamada Y; Okamura H; Ishibashi K; Noda T; Nagase S; Miyazaki A; Sakaguchi H; Shiraishi I; Makiyama T; Ohno S; Itoh H; Watanabe H; Hayashi K; Yamagishi M; Morita H; Yoshinaga M; Aizawa Y; Kusano K; Miyamoto Y; Kamakura S; Yasuda S; Ogawa H; Tanaka T; Sumitomo N; Hagiwara N; Fukuda K; Ogawa S; Aizawa Y; Makita N; Ohe T; Horie M; Aiba T
    JAMA Cardiol; 2019 Mar; 4(3):246-254. PubMed ID: 30758498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and genetic background of congenital long-QT syndrome diagnosed in fetal, neonatal, and infantile life: a nationwide questionnaire survey in Japan.
    Horigome H; Nagashima M; Sumitomo N; Yoshinaga M; Ushinohama H; Iwamoto M; Shiono J; Ichihashi K; Hasegawa S; Yoshikawa T; Matsunaga T; Goto H; Waki K; Arima M; Takasugi H; Tanaka Y; Tauchi N; Ikoma M; Inamura N; Takahashi H; Shimizu W; Horie M
    Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):10-7. PubMed ID: 19996378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical aspects of the three major genetic forms of long QT syndrome (LQT1, LQT2, LQT3).
    Kutyifa V; Daimee UA; McNitt S; Polonsky B; Lowenstein C; Cutter K; Lopes C; Zareba W; Moss AJ
    Ann Noninvasive Electrocardiol; 2018 May; 23(3):e12537. PubMed ID: 29504689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome.
    Schneider HE; Steinmetz M; Krause U; Kriebel T; Ruschewski W; Paul T
    Clin Res Cardiol; 2013 Jan; 102(1):33-42. PubMed ID: 22821214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long QT syndrome in adults.
    Sauer AJ; Moss AJ; McNitt S; Peterson DR; Zareba W; Robinson JL; Qi M; Goldenberg I; Hobbs JB; Ackerman MJ; Benhorin J; Hall WJ; Kaufman ES; Locati EH; Napolitano C; Priori SG; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
    J Am Coll Cardiol; 2007 Jan; 49(3):329-37. PubMed ID: 17239714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.